LABD vs LABU: Leverage, Returns & Decay
Over three months to Nov 13, 2026, against its daily multiple, compounded, LABD finished 3.8 points over and LABU 2.0 points short.
- Return gap
- +143.1 pts1 year to Nov 13, 2026: LABU ahead, total return
- Fee gap
- 0.11 ptsA year: LABD 1.07%, LABU 0.96%, per filings dated Mar 3, 2026
- Overlap
- –No book read for both funds
- Net flow
- −$71m / −$50mLABD / LABU, Oct 13, 2026 to Nov 12, 2026, daily basis
Compare two other funds
Growth of 100
Drawn from the numbers on this page. Growth of 100, both funds, distributions reinvested
LABD −72.8%, LABU +70.3%: LABU +143.1 pts ahead, 1 year, Nov 13, 2025 to Nov 13, 2026.
ShareUse this comparison
Client brief:
The two-page PDF for this pair is coming. Save the comparison to follow its changes. Free. It needs an email sign-in, once.
Fees over time
Hypothetical. $10,000 in LABD for 10 years at 1.07% a year costs about $1,728 in fees and lost growth; LABU at 0.96% would cost $1,557. Assumes 6% a year before fees, a sample rate, not a forecast.
How each fund moved
LABD returned −0.9% while −3 times XBI's move would have been +13.2%. Data from Aug 14, 2026 to Nov 13, 2026.
LABD returned −0.9% while −3 times XBI's move would have been +13.2%. Data from Aug 14, 2026 to Nov 13, 2026.LABU returned −22.3% while 3 times XBI's move would have been −13.2%. Data from Aug 14, 2026 to Nov 13, 2026.
Data from Aug 14, 2026 to Nov 13, 2026.IQ Leverage Score
How closely it delivered its daily multiple over 3 months, ranked against 19 inverse ETFs at 3x, over three months and 31 leveraged ETFs at 3x, over three months. 100 is best.
LABU scores higher · Did it keep up with its own daily multiple, compounded day by day, over three months?
LABD among the 19 inverse ETFs at 3x, over three months
LABU among the 31 leveraged ETFs at 3x, over three months
A percentile among the 19 inverse ETFs at 3x, over three months. LABU is a percentile among the 31 leveraged ETFs at 3x, over three months, a different set, so the two marks are not on one scale. Three months only, against the fund's own daily multiple; a different quarter can rank it very differently.
Key numbers
LABU costs 0.11 points a year less; their one-year returns differ by 143.1 points; LABU is 6.8 times larger.
Pair scorecard
Open the table
Points (pts) are percentage points.
| Total return, 1 year | −72.8% | +70.3% |
|---|---|---|
| What its daily multiple gave, 3 months | −4.7% | −20.3% |
| What it tracks | S&P Biotech | S&P Biotech |
| Expense ratio | 1.07% | 0.96% |
| Net assets, as of Nov 12, 2026 | $79m | $540m |
| Holdings in common | not published |
The numbers behind it
Net assets on Nov 12, 2026: $79m for Direxion Daily S&P Biotech Bear 3X ETF and $540m for Direxion Daily S&P Biotech Bull 3X ETF.
Side by side
Open the table
| Fund | Direxion Daily S&P Biotech Bear 3X ETF · Aims to return three times the opposite of the daily move of biotech (XBI) | Direxion Daily S&P Biotech Bull 3X ETF · Aims to return three times the daily move of biotech (XBI) |
| Issuer | Direxion | Direxion |
| Sets out to return | −3x | +3x |
| Underlying asset | XBI | XBI |
| Segment | sector | sector |
| Fund returned, 3 months | −0.9% | −22.3% |
| Underlying returned, over that window | −4.4% | −4.4% |
| What the stated multiple implies, over that window | +13.2% | −13.2% |
| Difference from stated, over that window | −14.1 pts | −9.1 pts |
| Fund returned, 1 year | −72.8% | +70.3% |
| Difference from stated, over that window | not available | −35.0 pts |
| Underlying volatility | 35% | 35% |
| Expense ratio | 1.07% | 0.96% |
| First traded | May 28, 2015 | May 28, 2015 |
| Net assets, as of Nov 12, 2026 | $79m | $540m |
As of Nov 13, 2026. Source: ETFIQ.
Window by window
Open the full table
| 1 month | −14.1% | +2.3% | −7.8% | +7.8% | −6.3 pts | −5.5 pts |
|---|---|---|---|---|---|---|
| 3 months | −0.9% | −22.3% | +13.2% | −13.2% | −14.1 pts | −9.1 pts |
| 6 months | −48.9% | +24.5% | −45.9% | +45.9% | −3.0 pts | −21.4 pts |
| 1 year | −72.8% | +70.3% | not meaningful | +105.3% | not meaningful | −35.0 pts |
| 3 years | −96.0% | +238.0% | not meaningful | not meaningful | not meaningful | not meaningful |
| Since launch (LABD May 2015 · LABU May 2015) | −100.0% | −93.0% | not meaningful | +285.0% | not meaningful | −378.0 pts |
From Jun 2015 to Nov 2026, LABU returned slightly more: −93.5% to −100.0%. LABD and LABU swung about the same: 92.6% and 94.0%. LABD and LABU fell about the same at their worst: −100.0% and −99.0%.
Full scorecard
Open the full table
| Total return | −100.0% | −93.5% | +90.0% | LABU (slight) | Price change plus distributions, reinvested. |
| Annualized | −54.5% | −21.2% | +5.7% | LABU | Total return as a yearly rate. |
| Price return | −100.0% | −93.7% | +86.1% | LABU (slight) | Price change alone, distributions left out. |
| Volatility | 92.6% | 94.0% | 31.1% | Tie | Spread of weekly returns, annualized. Lower is steadier. |
| Downside deviation | 65.7% | 61.9% | 21.0% | LABU (slight) | Like volatility, counting only weeks below the Treasury bill rate. |
| Max drawdown | −100.0% | −99.0% | −61.5% | Tie | Deepest fall from a high to the low after it. |
| Upside capture | −23.2% | Not measured | 100.0% | Share of its benchmark's rise caught in the weeks it rose. | |
| Downside capture | Not measured | 121.7% | 100.0% | Share of its benchmark's fall taken in the weeks it fell. Lower is better. | |
| Beta | −2.95 | 3.01 | 1.00 | LABD lower | How far it moves for each 1% its benchmark moves. |
| R squared | 0.98 | 0.99 | 1.00 | Not an edge | Share of its weekly moves its benchmark explains. |
| Sharpe | −0.41 | 0.19 | 0.26 | LABU | Return above Treasury bills per unit of volatility. |
| Sortino | −0.57 | 0.29 | 0.39 | LABU | Return above Treasury bills per unit of downside deviation. |
| Treynor | 0.127 | 0.059 | 0.082 | LABD | Return above Treasury bills per unit of beta. |
| Calmar | −0.55 | −0.21 | 0.09 | LABU | Annualized return divided by the max drawdown. |
| Benchmark | XBI | XBI | XBI | The ETF each fund is measured against. | |
| Alpha | −13.4% a year | −6.7% a year | 0.0% | Both significant | Yearly return beyond what its beta to the benchmark predicts. |
| Alpha t-stat | −3.38 | −3.20 | Not an edge | How sure the alpha is. Below 2, it could be chance. | |
| Alpha range | −21.3% to −5.6% | −10.9% to −2.6% | The 95% range for the yearly alpha. | ||
| Information ratio | −0.37 | 0.15 | LABU | Return against its benchmark per unit of tracking error. | |
| Tracking error | 123.5% | 63.0% | 0.0% | Not an edge | How far weekly returns stray from the benchmark, annualized. |
More
Computed by ETFIQ from Tiingo daily prices and ETFIQ's distribution records, 597 weekly returns. Cash rate: the 13-week Treasury bill.
About LABD
Over the three months to Nov 13, 2026, LABD lost 0.9%, against −4.7% for three times the inverse of XBI's daily moves. Read the multiple against the whole window instead and −3 times XBI's −4.4% implies +13.2%, which makes LABD look 14.1 points short. That is not the fund's objective, which is daily. Of that 14.1, daily compounding is −17.9 points, which any −3 times fund would show over the same path, and the fund itself is +3.8 points against −3 times each day's move, compounded. LABD aims to return -3 times XBI's move each day, then resets. Over one day it does that. Over longer periods the daily results compound, so the total is not -3 times the period's move: it is lower after a fall and recovery, and can be higher in a steady run. XBI moved at 35% annualized over that window. The more it moves, the further the two numbers separate.
About LABU
Over the three months to Nov 13, 2026, LABU lost 22.3%, against −20.3% for three times XBI's daily moves. Read the multiple against the whole window instead and 3 times XBI's −4.4% implies −13.2%, which makes LABU look 9.1 points short. Of that 9.1, daily compounding is −7.1 points, which any 3 times fund would show over the same path, and the fund itself is −2.0 points against 3 times each day's move, compounded. LABU aims to return +3 times XBI's move each day, then resets. Over longer periods the daily results compound, so the total is not +3 times the period's move: it is lower after a fall and recovery, and can be higher in a steady run.
Questions people ask
Which came closer to its daily multiple, LABD or LABU?
Over the window to Nov 13, 2026, LABD finished 14.1 points from what its multiple implies and LABU finished 9.1 points from its own, so LABU came closer. Neither number predicts the next window: it depends on how much the underlying moves about.
Are LABD and LABU levered on the same thing?
Yes. Both are levered on biotech, LABD at -3 times and LABU at +3 times the daily move.
Which one decays faster, LABD or LABU?
Decay follows how much the underlying moves about. Over this window LABD’s moved at 35% annualized and LABU’s at 35%, so LABD has the rougher ride and, at the same multiple, loses more to compounding.
Can I hold LABD or LABU for a year?
Both reset every day, so the multiple in the name applies to a single day, and daily results compound. Over a year the total is not the multiple times the year’s move; after a fall and recovery it is lower.
Other comparisons
Sources
More
Links are sources, not endorsements. A comparison is not a recommendation.
Copy and cite
Cite this pageCitation, APA and Markdown
ETFIQ, LABD against LABU, data as of Nov 13, 2026. https://etfiq.com/compare/leverage/labd-vs-labu
ETFIQ. (Nov 13, 2026). LABD against LABU. Retrieved from https://etfiq.com/compare/leverage/labd-vs-labu
[LABD against LABU (ETFIQ, Nov 13, 2026)](https://etfiq.com/compare/leverage/labd-vs-labu)
Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.